Literature DB >> 15390130

Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease.

Francesca Romana Pezzella1, Carlo Colosimo, Nicola Vanacore, Simone Di Rezze, Melania Chianese, Giovanni Fabbrini, Giuseppe Meco.   

Abstract

Hedonistic homeostatic dysregulation (HHD) is a neuropsychiatric disorder recently described in Parkinson's disease (PD), which is characterized by self-medication and addiction to dopaminergic drugs. To understand the prevalence of this disorder, we screened 202 PD patients attending our movement disorder unit for HHD. The clinical features of the patients identified as affected by this syndrome were then compared with those of control PD patients in an attempt to ascertain the possible risk factors for HHD. Results showed 7 subjects who fulfilled the HHD criteria. The analysis of a case-control study showed a significant correlation between HHD and a previous history of mood disorders, and the use of dopamine agonists, either in monotherapy or in combination. The prevalence of HHD in our study is similar to the one reported in the United Kingdom by the authors who first described this syndrome in PD. Of interest, our patients showed a somewhat different pattern of the disorder, suggesting that cultural and environmental factors may play a role in the phenomenology of HHD. (c) 2004 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15390130     DOI: 10.1002/mds.20288

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  27 in total

1.  Pramipexole and compulsive masturbation.

Authors:  Randy A Sansone; Mark Ferlan
Journal:  Psychiatry (Edgmont)       Date:  2007-09

Review 2.  Evidence for the use of cannabinoids in Parkinson's disease.

Authors:  Carsten Buhmann; Tina Mainka; Georg Ebersbach; Florin Gandor
Journal:  J Neural Transm (Vienna)       Date:  2019-05-27       Impact factor: 3.575

Review 3.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

4.  Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database.

Authors:  Nadège Rouve; Haleh Bagheri; Norbert Telmon; Atul Pathak; Nicolas Franchitto; Laurent Schmitt; Daniel Rougé; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2011-06-08       Impact factor: 2.953

Review 5.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

6.  Is a 'general' theory of addiction possible? A commentary on: a multistep general theory of transition to addiction.

Authors:  Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2014-06-03       Impact factor: 4.530

7.  Higher zinc concentrations in hair of Parkinson's disease are associated with psychotic complications and depression.

Authors:  Altair Brito Dos Santos; Marcos A Bezerra; Marcelo E Rocha; George E Barreto; Kristi A Kohlmeier
Journal:  J Neural Transm (Vienna)       Date:  2019-07-11       Impact factor: 3.575

Review 8.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

Review 9.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  Impulse control disorders in Parkinson's disease.

Authors:  Mark Stacy
Journal:  F1000 Med Rep       Date:  2009-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.